ZAS3 represses NFκB-dependent transcription by direct competition for DNA binding
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
NFκB and ZAS3 are transcription factors that control important cellular processes including immunity, cell survival and apoptosis. Although both proteins bind the κB-motif, they produce opposite physiological consequences; NFκB activates transcription,promotes cell growth and is often found to be constitutively expressed in cancer cells, while ZAS3 generally represses transcription, inhibits cell proliferation and is downregulated in some cancers. Here, we show that ZAS3 inhibits NFκB-dependent transcription by competing with NFκB for the κB-motif. Transient transfection studies show that N-terminal 645 amino acids is sufficient to repress transcription activated by NFκB, and that the identical region also possesses intrinsic repression activity to inhibit basal transcription from a promoter. Finally, in vitro DNA-protein interaction analysis shows that ZAS3 is able to displace NFκB by competing with NFκB for the κB-motif. It is conceivable that ZAS3 has therapeutic potential for controlling aberrant activation of NFκB in various diseases.
Abstract
NFκB and ZAS3 are transcription factors that control important cellular processes including immunity, cell survival and apoptosis. Although both proteins bind the κB-motif, they produce opposite physiological consequences; NFκB activates transcription,promotes cell growth and is often found to be constitutively expressed in cancer cells, while ZAS3 generally represses transcription, inhibits cell proliferation and is downregulated in some cancers. Here, we show that ZAS3 inhibits NFκB-dependent transcription by competing with NFκB for the κB-motif. Transient transfection studies show that N-terminal 645 amino acids is sufficient to repress transcription activated by NFκB, and that the identical region also possesses intrinsic repression activity to inhibit basal transcription from a promoter. Finally, in vitro DNA-protein interaction analysis shows that ZAS3 is able to displace NFκB by competing with NFκB for the κB-motif. It is conceivable that ZAS3 has therapeutic potential for controlling aberrant activation of NFκB in various diseases.
참고문헌 (24)
- Pierce, J. W., "Oligonucleotide that binds nuclear factor NF-κB acts as a lymphoid-specific and inducible enhancer element", Proc. Natl. Acad. Sci. U.S.A., 통권 : 85, pp.1482~1486 (1988)
- Oeckinghaus, A., "The NF-kB Family of Transcription Factors and its regulation", Cold Spring Harb. Perspect. Biol., 1, pp.a000034~ (2009)
- Chen, G., "TNF-R1 signaling: a beautiful pathway", Science, 296, pp.1634~1635 (2002)
- Gilmore, T., "Rel", NF-κB, Cancer Lett., pp.2002, 181[DOI]
- Allen, C. E., "The κB transcriptional enhancer motif and signal sequences of V(D)J recombination are targets for the zinc finger protein HIVEP3", KRC: a site selection amplification binding study, 2002, pp.3, 10~
- Wu, L. C., "ZAS: C2H2 zinc finger proteins involved in growth and development", Gene Expr., 10, pp.137~152 (2002)
- Fujii, H., "Frequent down-regulation of HIVEP2 in human breast cancer", Breast Cancer Res. Treat., 91, pp.103~112 (2005)
- Aalto, Y., "Distinct gene expression profiling in chronic lymphocytic leukemia with 11q23 deletion", Leukemia, 15, pp.1721~1728 (2001)
- Allen, C. E., "Developmental anomalies and neoplasia in animals and cells deficient in the large zinc finger protein KRC", Genes Chromosomes Cancer, 35, pp.287~298 (2002)
- Oukka, M., "A mammalian homolog of Drosophila schnurri, KRC, regulates TNF receptor-driven responses and interacts with TRAF2", Mol. Cell, 9, pp.121~131 (2002)
- Hong, J. W., "Inhibition of NF-κB by ZAS3, a zinc-finger protein that also binds to the κB motif", Proc. Natl. Acad. Sci. U.S.A., 통권 : 100, pp.12301~12306 (2003)
- Levine, M., "Transcriptional repression of eukaryotic promoters", Cell, 59, pp.405~408 (1989)
- Ayer, D. E., "Mad proteins contain a dominant transcription repression domain", Mol. Cell Biol., 16, pp.5772~5781 (1996)
- Fleischer, T. C., "Identification and characterization of three new components of the mSin3A corepressor complex", Mol. Cell Biol., 23, pp.3456~3467 (2003)
- Kakidani, H., "GAL4 activates gene expression in mammalian cells", Cell, 52, pp.161~167 (1988)
- Ptashne, M., "A genetic switch" (1986), Cell Press and Blackwell Scientific Publications
- Ghosh, S., "Missing pieces in the NF-κB puzzle", Cell, 109, pp.S81~S96 (2002)
- Han, K., "Transcriptional repression by the Drosophila even-skipped protein: definition of a minimal repression domain", Genes Dev., 7, pp.491~503 (1993)
- Han, K., "Functional domains of the Drosophila Engrailed protein", EMBO J., 12, pp.2723~2733 (1993)
- Sigler, P. B., "Transcriptional activation. Acid blobs and negative noodles", Nature, 333, pp.210~212 (1988)
- Ptashne, M., "How eukaryotic transcriptional activators work", Nature, 335, pp.683~689 (1988)
- Nissen, R. M., "The glucocorticoid receptor inhibits NFκB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain", Genes Dev., 14, pp.2314~2329 (2000)
- Gerritsen, M. E., "CREB-binding protein", p300 are transcriptional coactivators of p65, 1997, pp.통권 : 94, 2927~2932
- Papin, S., "The tumor necrosis factor α-dependent activation of the human mediterranean fever (MEFV) promoter is mediated by a synergistic interaction between C", EBPβ and NFκB p65, 2003, pp.278, 48839~48847